The platelet content of a clot may be at least as strong a predictor of outcome and mortality following mechanical thrombectomy as fibrin content, new data suggest. Researchers analyzed clot ...

BARCELONA, Spain — In stroke due to basilar artery occlusion, the best technique to use for thrombectomy appears to depend on the underlying etiology of the clot, a new trial suggested. The Chinese ...

Please provide your email address to receive an email when new articles are posted on . A novel thrombectomy system beat safety and efficacy performance goals for treatment of patients with pulmonary ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted 510(k) clearance to a Bay Area commercial stage medical technology company for its novel ...

HELSINKI, Finland—Patients with acute ischemic stroke caused by a large-vessel occlusion (LVO) who are undergoing endovascular thrombectomy fare better when intravenous tenecteplase (TNK) is ...

CHOICE2 randomized 400 patients across 14 Spanish centers to thrombectomy alone versus thrombectomy plus intraarterial alteplase, with 90-day mRS as the primary endpoint. Excellent outcomes (mRS 0–1) ...

For stroke patients, late administration of tenecteplase improved clinical outcomes in situations in which thrombectomy was not available immediately, according to the Chinese TRACE-III trial.

Thrombectomy does not improve outcomes among patients with acute ischemic strokes caused by blockages in the medium or distal vessels, results of three randomized trials indicate. Adding endovascular ...

The TESLA trial was unable to support a benefit to thrombectomy for stroke patients with large-core infarcts identified on noncontrast CT within 24 hours. Unlike other studies, endovascular therapy in ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the 82cm version of its Symphony™ 16F Catheter, the company’s ...